SCHEMBL25789501

SCHEMBL25789501

CC1(C)c2cc(-c3cn4ccccc4n3)ccc2-c2ccc(-c3nc(-c4ccc5ccccc5c4)nc(-c4ccc5ccccc5c4)n3)cc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 12/20 0.51
▸ NPC1 O15118 11/20 0.51
▸ KDM4E B2RXH2 10/20 0.51
▸ ALDH1A1 P00352 9/20 0.51
▸ SMN1; SMN2 Q16637 7/20 0.51
▸ PKM P14618 5/20 0.51
▸ MAPK1 P28482 2/20 0.51
▸ HSD17B10 Q99714 2/20 0.51
▸ HPGD P15428 2/20 0.51
▸ TP53 P04637 1/20 0.51
▸ TSHR P16473 1/20 0.51
▸ GFER P55789 3/20 0.49
▸ MEN1 O00255 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ EPHX2 P34913 1/20 0.49
▸ GAA P10253 1/20 0.49
▸ MIF P14174 1/20 0.49
▸ POLB P06746 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ TLR9 Q9NR96 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25789424 0.91 RAB9A (0.53) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL25789449 0.90 RAB9A (0.52) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL25789487 0.88 KDM4E (0.50) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL25789494 0.84 KDM4E (0.45) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL15382774 0.84 RAB9A (0.60) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL29614084 0.83 RAB9A (0.68) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL13325743 0.83 RAB9A (0.68) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL25789478 0.82 RAB9A (0.44) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL25789224 0.82 RAB9A (0.45) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL25789127 0.82 RAB9A (0.57) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230217820-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2023-07-06 — — US disclosed
US-20230217820-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2023-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230217820-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME TELO2, SOD1, TERT RAB9A 2202/4885NPC1 3704/4885KDM4E 3809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback